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Summary  
The effects of inflammation on the biochemical nd biomechanical properties of articular cartilage at two sites (dorsal 
and palmar) from the radial facet of the equine third carpal bone were examined in response to a synovitis induced 
with Escherichia coli lipopolysaccharide (LPS). Four groups were studied. In group 1 synovitis was induced at time zero 
and evaluated at week 6. Group 2 was the sham-treated control for group 1. In group 3 synovitis was induced at time 
zero and evaluated at week 2. Group 4 was the sham-treated control for group 3. 
There was a significant increase (P < 0.05) in newly synthesized proteoglycan PG from both sites in group 3 as 
compared to the sham-treated groups and group 1. No significant difference in the endogenous PG concentration 
between groups or sites was detected. Sepharose CL-2B revealed two peaks of newly synthesized PG in all groups; an 
early peak (Kay 0.11-0.13) and a late peak (Kay 0.48-0.64). Newly synthesized PG profiles from sham-treated groups and 
group 3 were similar, but the group 3 PG profile exhibited a more pronounced early peak. Conversely, the PG profile 
from group 1 demonstrated a more prominent late peak. Electrophoresis and Western blot analysis of the pooled late 
PG peak fractions from the sham-treated and group 1 showed a single toluidine blue stained band from both sites which 
reacted with monoclonal antibody (MAb) 1C6. By contrast, the late peak from the palmar site in group 3 showed an 
additional faster moving component .on composite gels which did not react with MAb 1C6. 
There was a significant decrease in Poisson's ratio and a significant increase in cartilage thickness in groups 1 and 
3 which had received synovitis. The increase in cartilage thickness of groups 1 and 3 was also significantly affected 
by site (dorsal > palmar). There was no significant difference in aggregate modulus or permeability constant among 
groups. 
Primary joint inflammation induced by LPS alters the biochemical and biomechanical properties of the articular 
cartilage as a function of time and site. An increase in chondrocyte PG synthesis in the early period following synovitis 
may be a reparative response to the inflammatory insult. Continued alterations in the qualitative PG composition in 
the later period following synovitis may represent a shift in chondrocyte metabolism to repopulate the existing cartilage 
matrix. 
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Introduct ion 
THE CLINICAL DIAGNOSIS of jo int inf lammation is 
predicated upon the hal lmark signs of effusion, 
heat and pain. The gross changes of inf lammation 
detectable on the exterior jo int surfaces are l inked 
with macroscopic and microscopic alterat ions 
occurr ing in the inter ior of the joint [1-3]. In short,  
jo int effusion, heat and pain are represented by 
increased synovial  membrane hyperemia and 
Submitted 10 February 1995; accepted 10 October 1995. 
This work was supported by a grant from the Equine Research 
Council, The Ohio State University, Columbus, OH. Dr Palmer 
was supported by a NIAMS-NRSA fellowship. 
Address correspondence to:J. L. Palmer, Department ofClinical 
Sciences, Veterinary Medicine Teaching Hospital, College of 
Veterinary Medicine, Cornell University, Ithaca, NY 14853. 
(607) 253-3100 FAX: (607) 253-3056. 
th ickening and decreased synovial  fluid viscosity 
and clarity. These macroscopic  changes are related 
to well-defined microscopic events of the inf lamma- 
tory process including alterat ions in cell surface 
adhesion molecule expression, inf lammatory cell 
influx and the release of inf lammatory mediators 
and enzymes. The release of neutrophi l  or 
macrophage-derived mediators and/or enzymes, in 
turn, have been associated with alterat ions in 
chondrocyte metabol ism and carti lage extracellu- 
lar matr ix destruct ion [4]. The alterat ions in tissue 
homeostasis associated with the inf lammatory 
process are general ly assumed to occur uniformly 
throughout  he  joint. Conversely, the predisposi- 
t ion of art icu lar  cart i lage lesions in anatomical ly  
specific locations in pr imary or post-traumatic 
osteoarthr i t is  has been strongly associated with 
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alterations in joint, mechanics [5-7]. While 
location-dependant changes in the articular 
cartilage in response to mechanical alterations 
is clear, the nature of the joint hard tissue 
response to the inflammatory process has been 
incompletely investigated. Further investigation 
of the overall and topographical response of the 
articular cartilage to inflammation is required 
in order to determine if a selective capacity 
for destruction and recovery exists within the 
joint. 
The relationship and significance of topographi- 
cal variations of articular cartilage biomechanical 
and biochemical properties has been described for 
selected joints [8, 9]. Site-specific hanges in these~ 
properties have also been described in a canine 
model following an increase in the load applied to 
the articular tissues via exercise [10-12]. Recent 
studies also support a link between the location of 
naturally occurring osteochondral lesions associ- 
ated with post-traumatic osteoarthritis in the 
equine midcarpal joint and the innate biomechan- 
ical/biochemical characteristics of these sites 
[13-15]. From these studies it is hypothesized that 
the response of the articular cartilage to an 
inflammatory insult may be dependent upon its 
innate topographical diversity. For example, if an 
area of articular cartilage within a joint possesses 
less compressive resistance associated with re- 
duced proteoglycan content or a more permeable 
matrix organization, the effects of the inflamma- 
tory process would be expected to be more 
pronounced than when compared to an area with 
greater compressive stiffness, greater proteoglycan 
content or a less permeable matrix. In addition, the 
capability of the chondrocytes in a given site to 
respond to the inflammatory event may be 
inherently different han that of another site, and 
therefore the potential to repair even a minor 
insult may be variable. 
The induction of a mild to moderate synovitis 
which does not create grossly detectable cartilagi- 
nous damage provides a method to test this 
hypothesis [16]. The horse serves as an excellent 
model for several reasons. Namely, acute synovitis 
is a common clinical condition seen in the 
midcarpal joint o f  young race horses during 
training and racing. A large percentage of these 
horses will eventually be treated for post-traumatic 
osteoarthritis [17]. The frequency, severity and 
histopathological changes seen with in equine 
osteoarthritis are similar to that seen in man [18]. 
In addition, the relative size of the equine joint as 
compared to the dog or rabbit allows for the 
collection of adequate sample sizes to permit both 
biochemical and biomechanical nalyses from the 
same joint reducing within and between subject 
variability. 
Materials and methods  
GROUP SELECTION 
Ten horses were selected for study (mean age 6.6 
years, mean body weight 440.3 kg) on the basis of 
normal clinical orthopedic examination, radio- 
graphic examination and synovial fluid analysis. 
All procedures were approved by the Institutional 
Laboratory Animal Care and Use Committee. 
Horses were exercised on a high-speed treadmill 
(Swedish Sato, Uppsala, Sweden)for 20 min once 
weekly at 4 m/s for 4 weeks prior to the start of the 
study to acclimate horses to the treadmill and 
to standardize the level of activity on the joint 
between animals. Between exercise intervals, 
horses were individually housed in 12×12ft 
boxstalls. Horses were exercised at the same time 
period weekly throughout the course of the study. 
SYNOVITIS MODEL 
The use of Escherichia coli lipopolysaccharide 
(LPS) to create a mild to moderate synovitis in the 
equine joint has been previously reported [16]. 
Briefly, carpi of groups 1 and 3 (see below) were 
prepared for aseptic intra-articular injection of 
0.125ng LPS (serotype B:055) in 0.5ml sterile 
phosphate-buffered saline (PBS; pH 7.2). Intra-ar- 
ticular injections of LPS were repeated every 48 h 
for a total of four treatments to maintain the 
inflammation for a 1-week duration. The midcarpal 
joints of groups 2 and 4 (see below) received sham- 
treatment. Sham-treatment consisted of aseptic 
arthrocentesis without concurrent injection at 
similar time periods as groups 1 and 3. 
EXPERIMENTAL DESIGN 
Ten horses with 20 normal carpi were divided 
randomly into the following groups (Table I): group 
(1): synovitis induced at time zero and were 
evaluated at week 6; group (2): no synovitis induced 
at time zero but received sham-treatment and 
were evaluated at week 6; group (3): synovi- 
tis induced at time zero and were evaluated at week 
2; group (4): no synovitis induced but received 
sham-treatment and were evaluated at week 2. 
Tissue was harvested from carpi at the end of 
each study period from groups with synovitis 
(groups 1 and 3) or without synovitis (groups 2 and 
4) at either 2 weeks (groups 3 and 4) or at 6 weeks 
(groups I and 2) after intervention. Carpi were 
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Table I. 
Assignment of limbs to experimental procedures 
Experimental groups 
Group 1 Group 2 Group 3 Group 4 
Week (N = 4) (N = 6) (N = 6) (N = 4) 
0 Synovitis Sham-treated Synovitis Sham-treated 
1 




6 Termination Termination 
assigned to groups to avoid comparison of carpi 
from an individual horse for either the evaluation 
of time effects (week 2 to 6) or inflammation effects 
(synovitis or sham-treated). 
At the end of the study, comparisons were made 
between groups 1 and 2 to evaluate the effect of 
synovitis induced 6 weeks earlier; between groups 
3 and 4 to evaluate the effect of synovitis induced 
2 weeks earlier; groups 1 and 3 to evaluate the 
effect of time on carpi with synovitis; and groups 
2 and 4 to evaluate the effect of time on carpi 
without synovitis. 
TISSUE SAMPLING 
Horses were killed humanely with an overdose 
of sodium pentobarbital solution. Both midcarpal 
joints were aseptically opened and the art icular 
cartilage visually evaluated for gross fibril lation or 
erosion. Art icular cartilage specimens were col- 
lected from the central aspect of the radial facet 
divided into dorsal and palmar sections (Fig. 1). 
Specimens were collected using a power drill and 
core biopsy instrument designed to provide 
full-thickness plugs of approximately 2mm in 
diameter [19]. Each core biopsy site was continu- 
ously irrigated with Ringer's lactate solution 
(Baxter Healthcare Corp., Deerfield, IL, U.S.A.) 
during the harvesting procedure to retard thermal 
necrosis of the carti lage plugs. Cartilage plugs 
were individually examined during collection to 
determine the presence of subchondral bone, which 
if found was dissected. Cartilage plugs from dorsal 
and palmar sites were immediately placed into 
separate transfer vials containing chilled Dul- 
becco's modified Eagle's medium (DMEM; Gibco, 
BRL, Gaithersburg, MD, U.S.A.). 
PROTEOGLYCAN BIOSYNTHESIS 
Articular cartilage from each site and animal 
were removed from the transfer vials and cultured 
in individual culture wells (35 mm in diameter) 
containing 3 ml DMEM supplemented with 10% 
(v/v) fetal bovine serum. To each culture, 40 #Ci 
of 35[S]Na2SO4 (New England Nuclear Research 
Products, Boston, MA, U.S.A.) in 0.5 ml DMEM 
media was added to radiolabel newly synthesized 
proteoglycans. Explant cultures were incubated 
at 37°C for 18 h in an atmosphere of 5% CO2/95% 
air. Following incubation, the cartilage plugs 
were removed and rinsed four times with sterile 
PBS. Subsequent biochemical analyses was 
Dorsal 
FIG. 1. Carpal joint anatomy and collection sites (inset) 
from the radial facet of the equine third carpal bone. 
Sites A (dorsal) and B (palmar) represent the central 
aspect of the radial facet which were used for 
proteoglycan analysis. Site C represents the medial 
aspect of the radial facet which was used for 
biomechanical analysis. Two sites on site C were 
evaluated by indentation testing and corresponded to
the middle of the dorsal portion and the middle of the 
palmar portion of the radial facet. RF, radial facet; IF, 
intermediate facet. 
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performed on articular cartilage explants from 
eight horses. 
Explants from each site and animal were 
extracted for 48h at 4°C with 5.0ml 4.0M 
guanidine hydrochloride (GuHC1; Sigma Chemical 
Co., St Louis, MO, U.S.A.)/0.1 M sodium acetate (pH 
5.8) containing the protease inhibitors; 6-amino- 
hexanoic acid (100 raM), disodium-EDTA (10 mM) 
and benzamidine (5 mM). Extracts were exhaus- 
tively dialyzed overnight at 4°C against distilled 
water (molecular cutoff, 6-8000; Spectrum Medical 
Industries, Inc., Houston, TX, U.S.A.) to remove 
unincorporated 35SO4 and to promote aggregation 
of the proteoglycan with hyaluronic acid in the 
GuHC1 extract. The volume of the non-dialyzable 
extract was recorded and radioactivity counted 
by the liquid-scintillation method in a Tri-carb 
Parkard model 3255 liquid-scintillation spec- 
trometry (Beckman, Model 3255, Palo Alto, CA, 
U.S.A.) using a 100pl aliquot of the total non- 
dialyzed volume (ICN Biochemicals, Costa Mesa, 
CA, U.S.A.). 
PROTEOGLYCAN CHARACTERIZATION 
The uronic acid content from each site and 
animal was determined on a 200-pl aliquot of the 
total non-dialyzed volume using a modified 
carbazole method with D-glucuronolactone as
standard [20]. Protein content was measured on a 
100-~l aliquot of the total non-dialyzed volume 
using the bicinchoninic acid assay with bovine 
serum albumin as standard [21]. The remaining 
non-dialyzable extract was pooled according to site 
and group, lyophilized and stored at -80°C for 
further analysis. 
Lyophilized samples from each site and group 
were suspended in 2 ml of 50% glycerol in 20 mM 
Tris-hydroxy buffer (pH 7.5) containing 100mM 
sodium chloride. To one-half of the 2-ml sample, 
10 pg of hyaluronic acid (human umbilical cord 
HA; Sigma Chemical Co., St Louis, MO, U.S.A.) was 
added and incubated at room temperature for 5 h. 
Both samples were chromatographed over a 
Sepharose CL-2B column (0.9 cmxl00 cm) (Phar- 
macia Fine Chemicals, Piscataway, NJ, U.S.A.) 
with 0.5M sodium acetate (pH 7.0) associative 
buffer. Void volume (Vo) and included volume (Vt) 
of the column were determined by blue dextran and 
35SO4, respectively. The chromatographic profile 
of newly synthesized 35SO4 labeled-proteoglycans 
was determined by counting 100pl of each 
fraction [22, 23]. Fractions eluted from the column 
which corresponded to the late PG peak (see 
below) were pooled, dialyzed overnight and 
lyophilized. 
Lyophilized 35SOclabeled material was reduced 
at 37°C for 4h with 10mM dithiothreitol dis- 
solved in 4 M GuHC1/1 mM Tris; pH 8.0 followed 
by alkylation with an equal volume of 80 mM 
iodoacetic acid in 4 M GuHC1/1 mM Tris; pH 8.0. 
This procedure derives the proteoglycan monomer 
hyaluronic acid binding region (HABR) for 
recognition of monoclonal antibody (MAb) 1C6 
(Hybridoma Bank, Baltimore, MD, U.S.A.). Follow- 
ing reduction/alkylation, samples were dialyzed at 
4°C overnight (molecular cutoff 2000) and 
lyophilized to reduce volume prior to electrophor- 
esis on composite agarose/polyacrylamide gels [24]. 
Reduced/alkylated samples were electrophoresed 
in duplicate on two slab gels; one gel was used for 
toluidine blue staining and the other for Western 
blotting with MAb 1C6. Slab gels were prerun for 
1 h at 50 V prior to loading samples. Samples were 
dissolved in running buffer (10mM Tris acetate 
buffer, pH 6.3/0.25 M sodium sulfate) followed by an 
equal volume of sample buffer [60% (w/v) sucrose 
with 0.01% (w/v) bromophenol b ue and 0.2% (v/v) 
Triton X-100]. The entire sample from each site was 
loaded onto the gel in order to maximize detection. 
Electrophoresis was carried out for 18 h at 4°C at 
50 V. 
Some gels were fixed (50% methanol and 10% 
acetic acid) for 1 h and subsequently stained with 
0.02% toluidine blue in 0.1 M acetic acid. Toluidine 
blue-stained gels were destained with 3% acetic 
acid. Each toluidine-stained gel was transferred to
a Gelbond film (FMC; Rockland, ME, U.S.A.) for 
20 min and films were dried in a 60°C incubator 
overnight. 
Some gels were used for Western blotting. These 
were placed on top of two layers of filter paper 
(Whatman No. 3 MM) and soaked in transfer buffer 
(0.125M Trizma base, 0.96M glycine and 12.5% 
methanol). Immobilon-P membrane (0.45/lm; Milli- 
pore, Boston, MA, U.S.A.) was pre-treated briefly 
with methanol and distilled water followed by 
equilibration in transfer buffer and placed on top 
of the gel followed by two additional pieces of 
soaked filter paper. Each filter paper/gel sandwich 
was placed into an electrotransfer apparatus (E-C 
Electroblot, St. Petersburg, FL, U.S.A.) containing 
cold transfer buffer. Gel transfer to Immobilon 
membrane was performed overnight at 4°C for 19 h 
at 0.4 amps. 
After transfer, Immobilon-P membranes were 
soaked in 3% gelatin in Tris-buffered saline 
(TBS; 20mM Tris and 500mM sodium chloride, 
pH 7.5) for lh  and then washed for 10rain in 
0.05% Tween-20-TBS (TTBS). Each membrane 
was incubated overnight with a 1:1000 dilution of 
MAb 1C6 in buffer (1% gelatin in TTBS) at room 
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temperature. Western blots were developed by 
washing each gel in TTBS for 10 min to remove 
MAb 1C6 and-then incubated with a 1:12 200 
dilution of an alkaline-phosphatase anti-mouse 
IgG antibody in antibody buffer for 2 h at room 
temperature. Membranes were washed twice more 
with TTBS (10 rain) followed by one wash in TBS 
(10 min). Membranes were subsequently incubated 
for 30min with a mixture of 3ml alkaline 
phosphate substrate (100 mM Tris, 100 mM NaC1, 
5mM magnesium chloride, pH 9.5) plus 20/tl 
nitro-blue tetrazolium and 10 #15-bromo-4-chloro-3- 
indolyl phosphate. Membranes were rinsed with 
distilled water and air-dried. 
The cartilage residue after GuHC1 extraction 
from dorsal and palmar sites in one horse from 
each group was completely dissolved in 2 N 
sodium hydroxide for 2 days a t  37°C, and then 
neutralized by an equal volume of 2 S hydrochloric 
acid for solubilization of all remaining gly- 
cosaminoglycan. Aliquots were removed from the 
final digest to determine uronic acid content. This 
value was then employed to determine the 
extraction efficiency of the GuHC1 method for 
horse cartilage PG. 
BIOMECHANICAL ANALYSIS 
Immediately after collection of samples for 
biochemical analysis, osteochondra] specimens 
were sectioned from the medial aspect of the radial 
facet immediately adjacent to the area selected for 
PG analysis (Fig. 1). Specimens were sectioned in 
the transverse plane at approximately 2 cm below 
the level of the proximal articular cartilage 
surface. Each specimen was briefly rinsed in PBS 
(pH 7.2) and thenstored at-80°C until indentation 
testing. At no time was any sample thawed prior 
to testing. Therefore, ach sample underwent only 
one freeze-thaw cycle prior to testing. Prior to 
indentation testing, each specimen was mounted in 
the testing machine holder with cyanoacrylate 
cement and thawed for I h at room temperature in a 
normal (0.15 M) saline solution containing protease 
inhibitors as previously described [25]. Specimens 
were maintained in the 'enzyme inhibitor bath' 
throughout the testing procedure. Two sites on 
each specimen were chosen for indentation testing, 
one located in the center of the dorsal aspect of the 
radial facet and one located in the center of the 
palmar aspect of the radial facet. At each site, the 
articular surface of the specimen was visually 
aligned perpendicular tothe porous indentor tip. 
Biphasic creep indentation and recovery testing 
was performed using a plane-ended circular porous 
microindentor (l.5mm) in a creep indentator 
testing apparatus [26]. A 0.02-N tare load was first 
applied at each site to ensure full contact between 
the articular cartilage surface and the indentor tip. 
The tare load was maintained until carti lage 
displacement reached an equilibrium, approxi- 
mately 1200 s. Following this, an instantaneous 
0.2-N test load was applied and cartilage displace- 
ment recorded until equilibrium was reached [25]. 
Cartilage creep recovery was performed at each site 
to confirm appropriate indentation testing appar- 
atus function and tissue health. Creep recovery 
displacement versus time data was collected over 
an 1800-s time period after removing the 0.2-N 
test load, but without altering the tare load. The 
per cent recovery at each site was calculated by 
dividing the absolute change in creep recovery 
displacement by the total creep indentation 
displacement. The total time required for align- 
ment, testing and recovery of each site was 
approximately 2-3 h per specimen. 
Cartilage thickness at each site was determined 
after creep recovery of the cartilage following 
indentation testing. Cartilage thickness was 
measured by driving a steel needle probe through 
the articular surface into the underlying subchon- 
dral bone and recording the force versus displace- 
ment data. Cartilage thickness was calculated by 
measuring the displacement between the force 
change as the needle probe contacted the art icular 
cartilage surface to when the needle probe 
contacted the subchondral bone plate. 
Cartilage displacement at equilibrium, cartilage 
thickness and indentator tip radius were used to 
calculate the intrinsic material properties of each 
site and specimen in a PC-adapted version of the 
linear KLM biphasic model of articular cartilage 
[27]. Included in this model are the aggregate 
modulus (HA), the permeability constant (k), and 
Poisson's ratio (rs). 
STATISTICAL ANALYSIS 
Statistical analysis was performed using a 
repeated measures mixed ANOVA for site and 
group corrected for variance among horses 
(Statistical Analysis Systems, Cary, NC, U.S.A.). 
Contrasts were evaluated with Bonferroni's correc- 
tion applied to the number of comparisons 
performed. P values <0.05 were considered 
significant. 
Since there was  no statistically significant 
differences in biochemical or biomechanical prop- 
erties between groups 2 and 4 (sham-treated), 
values for these groups were combined in the 
presentation of data. 
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Results 
CLINICAL AND PATHOLOGICAL OBSERVATIONS 
Joints injected with LPS exhibited mild to 
moderate synovitis with a mean + S.E.M. total 
nucleated cell count of 194.0 × 10 ~ cells/ 
1 + 63.06 × 10 ° cells/1 and total protein of 47.75 g/ 
1 + 3.3g/1 which began 12h after the initial 
injection. No changes in weight, 'attitude', appetite 
or systemic white blood cell count during the 
course of the study were noted. At death, the 
synovial membrane, synovial fluid and articular 
cartilage in each joint appeared grossly normal. 
PROTEOGLYCAN RESULTS 
There was a significant increase in newly-syn- 
thesized PG in group 3 when compared to groups 
2 and 4 (sham-treated) or to group i [Fig. 2(a)]. The 
site of collection had no effect on this difference 
(i.e. dorsal versus palmar) (data not shown). The 
significant increase in the newly-synthesized PG
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FIG. 2. Newly-synthesized (a) and endogenous (b) 
proteoglycan concentrations (mean _+ S.E.M.) of cartilage 
from sham-treated (groups 2 and 4), 2 weeks after 
synovitis (synovitis, week 2 group 3) and 6 -weeks after 
synovitis (synovitis, week 6 group 1). Differences between 
groups are reflected as an asterisk (*) notation over the 
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FIG. 3. Sepharose CL-2B profiles of cartilage from 
sham-treated (groups 2 and 4) (a), 2 weeks after synovitis 
(synovitis, week 2 group 3) (b) and 6 weeks after synovitis 
(synovitis, 6 group 1) (c). Vo is the void volume and VT is 
the total volume of the Sepharose CL-2B column. 
concentration i group 3 was not reflected in the 
endogenous PG concentration when compared to 
groups 2 and 4 (sham-treated) or group 1 [Fig. 2(b)]. 
There was no significant difference in either the 
newly synthesized or endogenous PGs of the 
articular cartilage between group 1 and groups 2 
and 4 (sham-treated). PG extraction efficiency was 
comparable among groups with an average PG 
extraction efficiency of 49.6%. 
Chromatographic profiles of newly synthesized 
PG differed considerably among the groups (Fig. 3) 
and between sites. All groups exhibited at least 2 
PG peaks on Sepharose CL-2B; an early peak (Kay 
0.11-0.13) and a later peak (Kay 0.48-0.64). Newly 
synthesized PG profiles from groups 2 and 4 
(sham-treated) [Fig. 3(a)] and group 3 [Fig. 3(b)] 
largely overlapped, with the exception of a more 
pronounced early peak in group 3 [Fig. 3(b)]. By 
comparison, the newly synthesized PG profile from 
group 1 [Fig. 3(b)] was very different. In addition, 
to a large decrease in ~SO4 associated with the 
early PG peak, the size of the PG in the later peak 
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tended to be hydrodynamically smaller [Fig. 3(c)]. 
Dorsal and palmar sites from groups 2 and 4 (sham- 
treated) and gl-oup 1 had similar PG chromato- 
graphic profiles, but the early peak was more 
pronounced in the sham-treated groups than in 
group 1. In group 3, the dorsal site cartilage showed 
an early PG peak which was more pronounced than 
the late PG peak, while PG from the palmar site 
demonstrated a broad PG peak which eluted from 
the column between the early and late PG peaks. 
Addition of HA to the samples did not alter the 
chromatographic profile in any group or in 
cartilage from either dorsal or palmar sites. 
The Kay of the early PG peak was consistent with 
PG of large hydrodynamic size. The Kay of the late 
PG peak was less well defined and therefore further 
examined to determine the nature of this PG 
subpopulation. The migration patterns from groups 
2 and 4 (sham-treated) and group 1 at dorsal or 
palmar sites did not differ. These samples exhibited 
a single band of PG (PG~) after staining with 
toluidine blue [Fig. 4(a), lane 1]. The migration rate 
was similar to human cartilage PG monomer A1D1 
which was electrophoresed simultaneously with 
the experimental samples [Fig. 4(a), lane 3]. These 
samples also reacted positively with MAb 1C6 on 
Western blots [Fig. 4(b), lanes 1 and 3]. A slab gel 
analysis of group 3 demonstrated a difference in 
the migration pattern for specimens collected from 
the palmar aspect of the facet only. In this area, 
there appeared to be 2 PG bands, PGI and PG~ 
[Fig. 4(a), lane 2]. PG~ migrated faster than either 
PG~ or human cartilage PG monomer A1D1 
[Fig. 4(a), lane 2]. Western blotting showed that 
this gel zone did not react with MAb 1C6 [Fig. 4(b), 
lane 2]. Specimens from the dorsal aspect of the 
radial facet from group 3 'showed a migration 
pattern similar to both dorsal and palmar sites of 
group 1, groups 2 and 4 (sham-treated) and human 
cartilage PG monomer A1D1 samples. Cartilage 






FIG. 4. Toluidine blue stained composite agarose/polyacrylamide gels (a) and Western blots with monoclonal ntibody 
(MAb) 1C6 (b) from cartilage GuHC1 extracts of the palmar aspect of the radial facet. Lane 1, sham-treated (groups 
2 and 4); lane 2, 2 weeks after synovitis (synovitis, week 2 group 3); lane 3, and human cartilage PG monomer A1D1. 
All samples were reduced/alkylated. Samples from sham-treated groups contained the proteoglycan population PGI, 
which migrated with human cartilage PG monomer A1D1 and reacted with MAb 1C6. Samples from cartilage specimens 
2 week after synovitis (synovitis, week 2 group 3) contained a similar migrating PGI subunit but also contained a PGn 
subunit which did not react with MAb 1C6 (arrow). 
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BIOMECHANICAL  RESULTS 
Poisson's rat io was s ignif icantly decreased in 
group 1 and group 3 as compared to groups 2 and 
4 (sham-treated), however, there was no effect of 
anatomical  site on Poisson's rat io [Fig. 5(a)]. 
Art icu lar  cart i lage thickness in group 1 and group 
3 was signif icantly greater  than  groups 2 and 4 
(sham-treated) [Fig. 5(b)]. Specimens col lected from 
the dorsal aspect of group 1 and group 3 were 
signif icantly thicker as compared to the pa lmar  
aspect [Fig. 5(b)]. There  was t rend (P= 0.07) for a 
signif icant increase in the aggregate modulus 
between group 1 and group 3 as compared to groups 
2 and 4 (sham-treated) [Fig. 5(c)]. While, there was 
no signif icant dif ference in the permeabi l i ty 
constant  between groups, there was a s ignif icant 
increase in the permeabi l i ty  constant  for pa lmar  
sites as compared to dorsal sites in all groups 
[Fig. 5(d)]. 
Discuss ion  
The results of the present study demonstrated an 
increase in chondrocyte newly synthesized PG, an 
a l terat ion in the hydrodynamic size of the 
predominant  synthesized PG, and an a l terat ion in 
the b iomechanical  propert ies of the ar t icu lar  
cart i lage in response to an inf lammatory process 
produced by LPS as both a funct ion of t ime and 
site. A companion study, demonstrated alterat ions 
in the synovial  f luid and synovial  membrane up to 
6 weeks fol lowing intra-art icu lar  LPS in ject ion 
[28]. While the classic inf lammatory changes (i.e. 
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FIG. 5. Biomechanical material properties (mean _+ S.E.M.) of cartilage Poisson's ratio (a), cartilage thickness (b), 
aggregate modulus (c) and permeability constant (d), from sham-treated (groups 2 and 4), 2 weeks after synovitis 
(synovitis, week 2 group 3) and 6 weeks after synovitis (synovitis, week 6 group 1). Different letter superscripts show 
a statistical difference among the groups (P < 0.05). Trends for differences (P < 0.1) between groups are reflected by 
a plus (+) notation over the column. Statistically significant differences between dorsal ([~) and palmar ( i )  sites are 
shown by an asterisk (*) notation over the column (P < 0.05). 
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total protein concentrations) were short-lived 
(resolving within 1 week), increased levels of 
synovial fluid eicosanoids, prostaglandin E2 and 
thromboxane B2 persisted. These findings corre- 
lated with synoviocyte hyperplasia 6 weeks 
following induced synovitis in the histopathologi- 
cal analysis of the synovial membrane. Therefore 
while the classic parameters associated with 
inflammation had subsided by 6 weeks, residual 
repair mechanisms might still be active in the joint. 
These results may suggest a link between the 
chondrocyte response to the presence of inflamma- 
tory mediators which presumably act to resolve and 
repair the cartilage matrix. 
The qualitative changes in the newly synthesized 
and endogenous PG were evident in the Sepharose 
CL-2B and the electrophoretic and Western blot 
profiles, respectively. In the groups 2 and 4 
(sham-treated), the newly-synthesized PG from 
dorsal and paImar sites consisted of approximately 
equal proportions of an early PG peak which in all 
likelihood is hydrodynamically large aggrecan (K~v 
0.11-1.13) and a late peak (Kay 0.48-0.64) which is 
likely to contain aggrecan fragments but may 
contain other hydrodynamically small PGs as well. 
All profiles represented the typical chromato- 
graphic profile of unpurified GuHC1 cartilage 
extracts and demonstrated the polydisperse nature 
of the newly-synthesized PG of equine articular 
cartilage. The fact that exogenous HA did not 
cause PG aggregate formation suggested that newly 
synthesized equine cartilage PG had a low affinity 
for HA as has been shown previously for newly 
synthesized human cartilage PG [29]. However, 
additional studies to determine the optimal 
proportions of HA to monomer must be conducted 
to prove this theory. Further analysis of pooled 
reduced/alkylated la te  peak fractions demon- 
strated a single PG monomer in the endogenous 
population (PG~) that exhibited a migration rate 
identical to human cartilage PG monomer (fraction 
A1D1). Human cartilage PG monomer AID1 and 
equine cartilage PG~ reacted with MAb 1C6 after 
reduction/alkylation, but PG~ (a significant com- 
ponent of group 3) did not. MAb 1C6 has been 
shown to react with the HABR (G1 domain) of 
aggrecan after reduction/alkylation a d with the 
G2 domain only after treatment of the latter with 
keratanase [30]. Since equine cartilage PG was 
transferred to Immobilon-P from composite gels 
directly without prior keratanase digestion, these 
results suggested that MAb 1C6 was reacting with 
equine HABR [31]. 
The chromatographic profile of carti lageexposed 
to synovitis 1 week earlier (group 3) differed 
between sites and when compared to the sham- 
treated groups. The dorsal cartilage site of group 3 
had a greater proportion of newly synthesized large 
PG, while the palmar site had a broad profile of 
both newly synthesized large and small PG. The 
reasons for this differential response are unknown, 
but reflect differences in the selective abil ity of 
chondrocytes from each site to respond to the 
synovitis or reflect difference in the relative 
location of each site to the synovial membrane. 
Qualitative analysis of the endogenous PG popu- 
lation demonstrated two populations of PG 
monomer subunits (PGI and PGn) in the palmar site 
of group 3. Since PGI migrated similarly in all 
groups and reacted with MAb 1C6, PGI probably 
represented a normal PG monomer constituent of 
the cartilage. However, PG~ from the palmar site of 
group 3 migrated faster in the gel in comparison to 
both the PGI and the human cartilage PG monomer 
A1D1 and did not react with MAb 1C6. Therefore 
PG~ may represent a degradation product in the 
matrix. The large increase in the newly synthesized 
PG monomer from this site seen on chromatog- 
raphy may reflect an attempt by the chondrocytes 
to replace PG monomer. Since the PGH band was 
not present in cartilage from group 1 it was 
possible that it undergoes further degradation 
eventually being released from the matrix during 
the 4-week period. 
The chromatographic profiles from dorsal and 
palmar sites were essentially identical in cartilage 
from joints exposed to synovitis 6 weeks earlier 
(group 1). However, these profiles still remained 
qualitatively different from the sham-treated 
groups in the relatively low proportion of large PG 
and the large contribution of small PG to the total 
newly synthesized PG population. Comparing these 
results with those obtained from group 3 suggested 
that this may represent a gradual shift of 
chondrocyte metabolism towards that which would 
normalize and replenish the endogenous popu- 
lation of PG in the articular cartilage matrix. 
Conversely, since large PG is the principle 
component of the articular cartilage matrix, the 
continued production of smaller PG species may 
also represent an alteration in chondrocyte 
activity as a result of the synovitis insult. However, 
the composite profiles and Western blots of the 
endogenous PG monomer from group 1 cartilage 
were indistinguishable from that of the sham- 
treated groups. This result further supported a 
reversion of the matrix to that seen without 
synovitis. 
Previous in vitro studies employing LPS stimu- 
lated articular cartilage explants demonstrated 
that an 0.001 pg/ml LPS concentration did not 
stimulate glycosaminoglycan (GAG) release over 
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control vaJues [32]. In addition, the hydrodynamic 
size or GAG concentration of PG has been shown 
to be reversible up to 8,days of continuous culture 
with LPS [33]. A recent report demonstrated that 
the response to equine cartilage explants to LPS is 
age-dependant, with cartilage harvested from a 
young horse (4-year-old) exhibiting a greater 
suppression of PG synthesis and a greater elease 
of GAG into the culture media as compared to an 
older horse (20-year-old) following a 3-day exposure 
to various concentrations of Salmonella typhosa- 
derived LPS [34]. In the present study, an increase 
in PG synthesis was detected in the early time 
period following in vivo injection of LPS. The 
differences in these studies may be associated 
with the presence of in vivo factors which are 
released in the inflammatory process either by the 
synovial membrane, cellular infiltrate or articular 
cartilage which may boost chondrocyte reparative 
mechanism to the inflammatory insult. 
The average PG extraction efficiency of equine 
full-thickness cartilage plugs harvested in this 
study was lower than that previously reported for 
freezer-milled human and rabbit cartilage under 
similar extraction conditions [23]. However, since 
there was no statistical difference among samples 
in PG extraction efficiency, the extraction method 
was consistent and supports group comparisons. 
The results of indentation testing indicated that 
the biochemical alterations seen in response to 
inflammation may be associated with changes in 
the biomechanical material properties which 
reflect the organizational structure of the articular 
cartilage xtracellular matrix. In the present study, 
Poisson's ratio of cartilage exposed to synovitis 
(group 1 and group 3) was significantly lower than 
in the sham-treated groups. A low Poisson's ratio is 
indicative of a tissue with greater compressibility. 
The decreased Poisson's ratio in group 1 and group 
3 suggests a change in the matrix organization 
which could allow for this expansion. The 
chromatographic profiles of group 1 and group 3 
demonstrated alterations in the newly synthesized 
PG as compared to the sham-treated groups and 
support this viewpoint. Group 1 and group 3 also 
had a significantly greater thickness than the 
sham-treated groups and a significantly greater 
thickness in the palmar site when compared to 
the dorsal site. This may suggest location- 
dependent swelling of the tissue in response to 
both degradative and synthetic events or matrix 
re-organizational events [35]. Since increased 
articular cartilage thickness and chondrocyte 
metabolism accompany early events in osteoar- 
thritis pathology, the large increase in articular 
cartilage thickness in the dorsal site in cartilage 
exposed to synovitis (group 1 and group 3) is of 
particular interest since this is the predominant 
site of osteochondral lesions in racehorses [36, 37]. 
In addition, a trend toward an increase in 
aggregate modulus of cartilage xposed to synovitis 
(group 1 and group 3) was noted. Since the 
aggregate modulus is an indicator of the overall PG 
content, the increased synthesis of PG in group 3 
and the large contribution of newly-synthesized PG
monomer in group 1 may contribute to this result. 
The results of this study extend previous 
contentions and provides new evidence that global 
joint inflammation may change the biochemical 
and biomechanical properties of the articular 
cartilage. We demonstrated that a mild short-lived 
synovitis resulted in early changes in the articular 
cartilage matrix. This study also supported the 
view that cartilage alterations in response to a 
joint injury may be location-dependent. Therefore, 
inflammation may play a primary role in cartilage 
response to initial injury. Repeated bouts of acute 
synovitis may weaken the articular cartilage 
structure and alter chondrocyte reparative mech- 
anisms. The salient novel finding of the present 
study was that quantitative and qualitative changes 
in the articular cartilage continue to progress after 
the 'inflammatory' response has largely subsided. 
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